Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prasugrel vs Ticagrelor in Korean STEMI Patients
NCT02075125Phase 3Terminated
- Sponsor
- Dong-A University
- Start
- Jan 2014
- Primary completion
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of prasugrel, ticagrelor in ST-segment elevation myocardial infarction (STEMI), sponsored by Dong-A University. Started Jan 2014; status: terminated.
02
Drugs
prasugrelticagrelor
03
Conditions
ST-segment elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT02075125.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02075125.